Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival
Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival
About this item
Full title
Author / Creator
Miah, Abdul , Tinoco, Gabriel , Zhao, Songzhu , Wei, Lai , Johns, Andrew , Patel, Sandip , Li, Mingjia , Grogan, Madison , Lopez, Gabrielle , Husain, Marium , Hoyd, Rebecca , Mumtaz, Khalid , Meara, Alexa , Bertino, Erin M. , Kendra, Kari , Spakowicz, Daniel , Otterson, Gregory A. , Presley, Carolyn J. and Owen, Dwight H.
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Journal title
Language
English
Formats
Publication information
Publisher
Berlin/Heidelberg: Springer Berlin Heidelberg
Subjects
More information
Scope and Contents
Contents
Purpose
Immune checkpoint inhibitors (ICIs) are associated with a unique set of immune-related adverse events (irAEs). Few studies have evaluated the risk factors and outcomes of patients who develop ICI-induced hepatitis (ICIH).
Methods
We utilized an institutional database of patients with advanced cancers treated with ICI to identify pa...
Alternative Titles
Full title
Immune checkpoint inhibitor-induced hepatitis injury: risk factors, outcomes, and impact on survival
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10191203
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10191203
Other Identifiers
ISSN
0171-5216
E-ISSN
1432-1335
DOI
10.1007/s00432-022-04340-3
